Resources | AI

Products
- For Providers
- For Life Sciences
Platform
Resources
Company
Press
- Media InsightRX in the news — digital, print, podcasts, and other outlets
- Press Releases Announcements for events, partnerships, and company updates

KLAS-emerging-company-spotlight

FEATURED POST

InsightRX Achieves 96.1 Performance Score in KLAS Spotlight as the First Precision Dosing AI Solution

Home
Resources
Blog

Search Blog section Author Tags

Thought Leadership

Feb 10, 2026

From Chatbots to Bedside-Ready AI Systems

Thought Leadership

Dec 11, 2025

Beyond the Hype: A Pragmatic Look at Machine Learning for Precision Dosing

Product Innovation

Sep 11, 2024

Choosing the right model for your patient: An introduction to InsightRX Gemini

Thought Leadership

Feb 27, 2024

Artificial Intelligence Drives Industry Response to Project Optimus

Thought Leadership

Oct 12, 2023

Using hybrid PKPD/ML models to accurately predict risk of neutropenia

Thought Leadership

Feb 28, 2023

What Does 2023 Hold for Biopharma? Part 5: Technological Advances

Thought Leadership

Jan 3, 2023

The 2023 PharmaVoice Crystal Ball: Peering into the future of life sciences

Thought Leadership

Dec 16, 2022

What to Expect from AI-Enabled Drug Discovery in 2023

Maximize therapeutic success with precision medicine.

What We Do

For Providers

Bayesian Dosing (MIPD)
Real-Time Dosing Analytics
Available Drug Modules

For Life Sciences

Precision Dosing in Clinical Trials
PKPD Analytics in Clinical Trials
Companion Applications

How We Do It

Continuous Learning
Integrations
Security & Regulatory
Success & Support
Data Science

Information

Resources

Product Innnovation
Scientific Publications
Thought Leadership
White Papers
How to Cite InsightRX

Press

Media
Press Releases

About

Contact Us
Customers
Leadership
Advisory Board
Mission & Vision
Careers

548 Market Street
#88083
San Francisco, CA 94104

Copyright © InsightRX, Inc.
740-05000-REC-01 08/2025

View our privacy policy

InsightRX Nova is not considered to be a medical device in the U.S. and has not been submitted to the U.S. Food and Drug Administration for review or clearance

548 Market Street
#88083
San Francisco, CA 94104